КОМПЛЕКСНАЯ ХАРАКТЕРИСТИКА НАРУШЕНИЙ ПРИ СИНДРОМЕ ШЕРЕШЕВСКОГО-ТЕРНЕРА

Авторы

  • Хайдарова Ф.А
  • Каланходжаева Ш.Б
  • Сиддиков А.А

Ключевые слова:

Синдром Шерешевского-Тернера, Х-хромосома, мозаицизм, кариотип

Аннотация

Синдром Шерешевского-Тернера - один из наиболее распространенных хромосомных аномалий, для которого характерно либо полное отсутствие одной хромосомы, либо наличие дефекта в одной из Х – хромосом. В результате хромосомных аномалий у девочек нарушается процесс созревания яичников, отмечается задержка или полное отсутствие полового созревания и как следствие, развитие бесплодия. В некоторых случаях (чаще при кариотипе 45,Х/ 46,ХY) может развиваться гонадобластома. В редких случаях у пациентов с Шерешевского-Тернера встречается спонтанный пубертат. Переход молодых женщин с СШТ от педиатрической ко взрослой помощи характеризуется высоким процентом отсева и неадекватным последующим наблюдением, что приводит к увеличению заболеваемости и смертности.

Библиографические ссылки

Aso K., Koto S., Higuchi A. et al. Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocrine journal. 2010; 57(10): 909–913.

Birkebaek N., Cruger D., Hansen J. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet 2002; 61: 359.

Bondy C. Pregnancy and cardiovascular risk for women with Turner syndrome. Women Health. 2015; 4: 1-9.

Bondy C., Turner T., Consensus S. et al. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2014; 92: 10-25.

Brun S., Berglund A., Mortensen K. et al. Blood pressure, sympathovagal tone, exercise capacity and metabolic status are linked in Turner syndrome. Clin Endocrinol (Oxf). 2019; 91(1): 148-155.

Bryman I., Sylven L., Berntorp K. et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertility and sterility. 2011; 95(8): 2507–2510.

Carrel L., Willard H. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434(7031): 400–404.

Chang S., Tucker T., Thorogood N., Brown C. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852–866.

Clement-Jones M., Schiller S., Rao E. et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9(5): 695–702.

Darendeliler F., Yes¸ilkaya E., Bereket A. et al. Growth curves for Turkish Girls with Turner syndrome: results of the Turkish Turner syndrome Study Group. J Clin Res Pediatr Endocrinol 2015; 7: 183–91.

Day G., Szvetko A., Griffiths L. et al. SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J Orthop Res. 2009; 27(6): 807-813.

Donadille B., Christin-Maitre S. Heart and Turner syndrome. Ann Endocrinol (Paris). 2021; 82(3-4): 135-140.

Donato B., Ferreira M. Cardiovascular risk in Turner syndrome. Rev Port Cardiol (Engl Ed). 2018; 37(7): 607-621.

Folsom L., Fuqua J. Reproductive Issues in Women with Turner Syndrome. Endocrinol Metab Clin North Am. 2015; 44(4): 723-737.

Gravholt C., Andersen N., Conway G. et al. International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3): G1-G70.

Gravholt C., Viuff M., Brun S. et al. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019; 15(10): 601-614.

Hadnott T., Gould H., Gharib A., Bondy C. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertility and sterility. 2011; 95(7): 2251–2256.

Hagman A., Loft A., Wennerholm U. et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Human reproduction. 2013; 28(6): 1598–1609.

Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatric endocrinology reviews: PER. 2012; 9(Suppl 2): 713–717.

Hreinsson J., Otala M., Fridström M. et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002; 87(8): 3618-3623.

Hutaff-Lee C., Bennett E., Howell S., Tartaglia N. Clinical developmental, neuropsychological, and social-emotional features of Turner syndrome. Am J Med Genet C Semin Med Genet. 2019; 181(1): 126-134.

Karnis M. Fertility, pregnancy, and medical management of Turner syndrome in the reproductive years. Fertility and sterility. 2012; 98(4): 787–791.

Kesler S. Turner syndrome. Child Adolesc Psychiatr Clin N Am. 2007; 16(3): 709-722.

Kosteria I., Kanaka-Gantenbein C. Turner Syndrome: transition from childhood to adolescence. Metabolism. 2018; 86: 145-153.

Mondal S., Bhattacharjee R., Chowdhury S., Mukhopadhyay S. Heterogeneity of Karyotypes in Turner Syndrome. Indian J Pediatr. 2021; 88(2): 175.

Moonga S., Pinkhasov A., Singh D. Obsessive-Compulsive Disorder in a 19-Year-Old Female Adolescent with Turner Syndrome. J Clin Med Res. 2017; 9(12): 1026–1028.

Negreiros L., Bolina E., Guimaraes M. Pubertal development profile in patients with Turner syndrome. Journal of Pediatric Endocrinology and Metabolism 2014; 27: 845–849.

Oktay K., Bedoschi G., Berkowitz K. et al. Fertility preservation in women with turner syndrome: a comprehensive review and practical guidelines. J Ped Adolescent Gynecol 2016; 29: 409–416.

Pasquino A., Passeri F., Pucarelli I. et al. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. The Journal of clinical endocrinology and metabolism. 1997; 82(6): 1810–1813.

Peeters S., Korecki A., Baldry S. et al. How do genes that escape from X-chromosome inactivation contribute to Turner syndrome? Am J Med Genet C Semin Med Genet. 2019; 181(1): 28-35.

Reynaud K., Cortvrindt R., Verlinde F. et al. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertility and sterility. 2004; 81(4):1112–1119.

Santi M., Flück C., Hauschild M. et al. Health behaviour of women with Turner Syndrome. Acta Paediatr. 2021; 110(8): 2424-2429.

Schoemaker M., Swerdlow A., Higgins C. et al United Kingdom Clinical Cytogenetics G. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008; 93(12): 4735-4742.

Tanaka T., Igarashi Y., Ozono K. et al. Frequencies of spontaneous breast development and spontaneous menarche in Turner syndrome in Japan. Clinical Pediatric Endocrinology. 2015; 24: 167–173.

Visser J., Hokken>Koelega A., Zandwijken G et al. Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Human Reprod 2013; 28: 1899–907.

Wu H., Li H. Karyotype classification, clinical manifestations and outcome in 124 Turner syndrome patients in China. Ann Endocrinol (Paris). 2019; 80(1): 10-15.

Загрузки

Опубликован

2022-12-23